Coloplast FY 2019/20 Roadshow Presentation

Coloplast's FY 2019/20 roadshow presentation highlights solid financial results across Ostomy Care, Continence Care, Wound & Skin Care, and Interventional Urology divisions despite COVID-19 pandemic impacts. The company achieved 4% organic growth with a 32% EBIT margin and introduced its "Strive25" strategy with long-term guidance of 7-9% organic growth annually.